MIR4787

Across TCGA pan-cancer cohorts, MIR4787 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR4787 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR4787 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4787 expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

THCA, MESO, and STAD are the cancer types where MIR4787 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.650	0.971	<.001	105	view →
MESO	OS	Tertile	III,IV	0.069	0.580	<.001	54	view →
STAD	OS	Median	All	0.368	0.621	.003	28	view →
ESCA	DFS	Median	III,IV	0.548	0.313	.010	27	view →
SARC	DFS	Tertile	All	0.222	0.637	.007	15	view →
BRCA	OS	Tertile	III,IV	0.123	0.547	.025	12	view →
UCEC	DFS	Tertile	All	0.730	0.898	.039	12	view →
PCPG	OS	Tertile	All	0.933	1.000	.025	9	view →
LIHC	OS	Tertile	II,III,IV	0.239	0.715	.035	9	view →
GBM	OS	Tertile	All	0.575	0.379	.048	3	view →
LUSC	DFS	Tertile	II,III,IV	0.853	0.348	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR4787–THCA (OS)

Open the THCA breakdown →